| __timestamp | Bausch Health Companies Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 4101058 |
| Thursday, January 1, 2015 | 582800000 | 10763215 |
| Friday, January 1, 2016 | 455000000 | 5579049 |
| Sunday, January 1, 2017 | 366000000 | 32051299 |
| Monday, January 1, 2018 | 414000000 | 24482286 |
| Tuesday, January 1, 2019 | 471000000 | 43892589 |
| Wednesday, January 1, 2020 | 452000000 | 44505000 |
| Friday, January 1, 2021 | 465000000 | 79406000 |
| Saturday, January 1, 2022 | 529000000 | 49283000 |
| Sunday, January 1, 2023 | 604000000 | 17282730 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, innovation is key. Bausch Health Companies Inc. and Verona Pharma plc are two players with distinct strategies. From 2014 to 2023, Bausch Health consistently outspent Verona Pharma on research and development (R&D), with an average annual investment nearly 15 times greater. In 2023, Bausch Health's R&D expenses peaked at approximately 604 million, a 146% increase from 2014. Meanwhile, Verona Pharma's highest investment was in 2021, reaching around 79 million, a significant leap from its 2014 figure. This disparity highlights Bausch Health's aggressive approach to innovation, while Verona Pharma's more modest spending reflects a focused, perhaps niche, strategy. As the pharmaceutical landscape evolves, these investment patterns may influence their competitive positions and market success.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Verona Pharma plc
Summit Therapeutics Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
Alpine Immune Sciences, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
R&D Insights: How Verona Pharma plc and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Verona Pharma plc and Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Comparing Innovation Spending: Perrigo Company plc and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Vericel Corporation
Analyzing R&D Budgets: Bausch Health Companies Inc. vs HUTCHMED (China) Limited